Jingdan Hu
6Patents
0h-index
12Co-inventors
42Inventor score
Filing activity: May 25, 2000 → Dec 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6403623B1 | Heterocyclic antituberculosis agents | Human Necessities | 0 | Expired |
| US12234239B2 | Crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile | Chemistry; Metallurgy | 0 | Active |
| US8168659B2 | 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US8426448B2 | 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands | Human Necessities | 0 | Active |
| US12304903B2 | Process for making an isoxazoline compound and intermediate thereof | Chemistry; Metallurgy | 0 | Active |
| US11548895B2 | Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.